Levi A. Garraway founded Foundation Medicine, Inc. and Tango Therapeutics Sub, Inc. Currently, he is Chief Medical Officer & Head-Product Development at Roche Holding AG and Director, Chief Medical Officer & Executive VP at Genentech, Inc. (a subsidiary of Roche Holding AG).

In his past career Levi A. Garraway held the position of Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. and Assistant Professor at Dana-Farber Cancer Institute, Inc.